1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Contributes to invasiveness in Anti-PKN beta抗体malignant prostate cancer.
Also known as:
PKN3; PKN3_HUMAN; PKNBETA; Protein kinase C related kinase 3; Protein kinase N3; Protein kinase PKN beta; Protein kinase Anti-PKN beta抗体PKN-beta; Protein-kinase C-related kinase 3; RP11-545E17.1; Serine/threonine protein kinase N3; Serine/threonine-protein kinase N3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated Anti-PKN beta抗体synthetic peptide derived from human PKN beta.
●
Predicted Molecular Weight: 106kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-PKN beta抗体
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.